Why Curaleaf Holdings (CNSX:CURA) Rose 10% in the Last Week

Why it’s advisable to buy Curaleaf Holdings Inc (CNSX:CURA) at the current price.

| More on:

Shares of leading cannabis company Curaleaf Holdings (CNSX:CURA) have risen 10% in the last week of August 2019. The stock is currently trading at $9.41. Despite the recent rally, Curaleaf shares are still trading 40% below their 52-week high.

Stock rose despite missing revenue and earnings estimate

Curaleaf is a Canada-based vertically integrated cannabis company in the U.S. Curaleaf announced its second-quarter results on August 27 and reported revenue of $48.5 million — a rise of 231% year over year.

In the prior-year period, Curaleaf sales stood at $14.65 million. The company’s bottom line increased significantly. It reported EBITDA of $3.35 million — way higher than the -$3.83 million figure in the second quarter of 2018.

However, Curaleaf’s loss widened to 24.5 million, or $0.05 per share, up from the loss of $4.93 million, or $0.01 per share, in the prior-year period. Analysts estimated Curaleaf sales of $49.8 million and earnings per share of -$0.01.

Curaleaf stock moved higher despite missing analyst estimates for the June quarter.

Growth via partnerships and acquisitions

Similar to peer cannabis companies, Curaleaf is looking to grow sales by several partnerships and acquisitions. It announced the acquisition of Select, which is a leading cannabis brand in the United States. The company also acquired the exclusive rights to operate one of the highest-grossing dispensaries in Arizona, which is the Emerald dispensary.

Curaleaf closed the acquisitions of Glendale Greenhouse and Phytotherapeutics Management Services as well this month.

Curaleaf announced the acquisition of Grassroots for $875 million, making the combined entity the largest cannabis player in the world. Post-acquisition, the combined entity will have a production capacity totaling 2.1 million square feet. Curaleaf will have the largest operational footprint in the U.S. and will operate in 19 states across 68 retail locations.

Another big acquisition was that of Cura for $1.27 billion, announced in May this year. Cura is a major cannabis brand on the West Coast. Cura is a market leader in Oregon, Nevada, California, and Arizona. It has 12 cultivation facilities, 11 processing facilities, and 45 retail locations across the U.S.

Strong revenue and earnings growth

These acquisitions will result in robust revenue and bottom-line growth for Curaleaf. The company reported sales of $19 million in 2017 and $77 million in 2018. Analysts expect sales to rise 232.5% to $256 million in 2019 and 259% to $919 million in 2020. While currently unprofitable, Curaleaf is expected to improve its net margin from -18.6% in 2019 to 15.3% in 2020.

Curaleaf was already a well-known brand on the East Coast. It has the largest footprint of branded retail stores in the U.S. and is uniquely positioned to capture market opportunities via recent acquisitions.

Huge market opportunity

While Curaleaf is a cannabis leader in terms of sales, it still has enough growth opportunities. It has the potential to grow its manufacturing footprint at a significant rate. Curaleaf’s vertical integration helps the company control the entire supply chain. After the major acquisitions undertaken recently, Curaleaf has a presence in 11 of the 12 major markets in the U.S.

Curaleaf management is optimistic about long-term growth. Company CEO Joseph Lusardi stated, “We have made significant progress over the last few months in executing on our strategy to become the leading vertically integrated multi-state cannabis operator in the United States. The recently announced acquisitions of Select and Grassroots, as well as, tuck in acquisitions in Arizona, California, Nevada and Ohio position Curaleaf as the undisputed leader in the cannabis industry.”

He added, “With the industry’s largest operational footprint, we have the scale to rapidly accelerate growth across the country. I continue to believe Curaleaf is the best positioned operator in the cannabis space with the potential to create substantial shareholder value.”

While Curaleaf stock has recently gained momentum, it has significant upside potential given increasing market presence, making it a safe bet for investors.

Should you invest $1,000 in Algonquin Power and Utilities right now?

Before you buy stock in Algonquin Power and Utilities, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Algonquin Power and Utilities wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $21,345.77!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*.

See the Top Stocks * Returns as of 4/21/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

Buy the Dip Before It’s Too Late: This Canadian Stock Won’t Stay Cheap Forever

Investors might think that cannabis stocks are out, but this one could be the top Canadian stock to consider.

Read more »

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »